Haemonetics Price to Sales Ratio 2010-2024 | HAE
Historical PS ratio values for Haemonetics (HAE) over the last 10 years. The current P/S ratio for Haemonetics as of September 19, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Haemonetics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-09-20 | 74.83 | 2.89 | |
| 2024-06-30 | 82.73 | $25.93 | 3.19 |
| 2024-03-31 | 85.35 | $25.47 | 3.35 |
| 2023-12-31 | 85.51 | $24.71 | 3.46 |
| 2023-09-30 | 89.58 | $24.14 | 3.71 |
| 2023-06-30 | 85.14 | $23.71 | 3.59 |
| 2023-03-31 | 82.75 | $22.71 | 3.64 |
| 2022-12-31 | 78.65 | $21.95 | 3.58 |
| 2022-09-30 | 74.03 | $21.05 | 3.52 |
| 2022-06-30 | 65.18 | $19.94 | 3.27 |
| 2022-03-31 | 63.22 | $19.37 | 3.26 |
| 2021-12-31 | 53.04 | $18.59 | 2.85 |
| 2021-09-30 | 70.59 | $18.22 | 3.88 |
| 2021-06-30 | 66.64 | $17.65 | 3.77 |
| 2021-03-31 | 111.01 | $16.98 | 6.54 |
| 2020-12-31 | 118.75 | $17.20 | 6.90 |
| 2020-09-30 | 87.25 | $17.53 | 4.98 |
| 2020-06-30 | 89.56 | $18.29 | 4.90 |
| 2020-03-31 | 99.66 | $19.15 | 5.21 |
| 2019-12-31 | 114.90 | $19.25 | 5.97 |
| 2019-09-30 | 126.14 | $18.92 | 6.67 |
| 2019-06-30 | 120.34 | $18.61 | 6.47 |
| 2019-03-31 | 87.48 | $18.34 | 4.77 |
| 2018-12-31 | 100.05 | $17.99 | 5.56 |
| 2018-09-30 | 114.58 | $17.72 | 6.47 |
| 2018-06-30 | 89.68 | $17.43 | 5.15 |
| 2018-03-31 | 73.16 | $17.02 | 4.30 |
| 2017-12-31 | 58.08 | $17.08 | 3.40 |
| 2017-09-30 | 44.87 | $17.05 | 2.63 |
| 2017-06-30 | 39.49 | $17.05 | 2.32 |
| 2017-03-31 | 40.57 | $17.17 | 2.36 |
| 2016-12-31 | 40.20 | $17.51 | 2.30 |
| 2016-09-30 | 36.21 | $17.73 | 2.04 |
| 2016-06-30 | 28.99 | $17.77 | 1.63 |
| 2016-03-31 | 34.98 | $17.81 | 1.96 |
| 2015-12-31 | 32.24 | $17.39 | 1.85 |
| 2015-09-30 | 32.32 | $17.26 | 1.87 |
| 2015-06-30 | 41.36 | $17.35 | 2.38 |
| 2015-03-31 | 44.92 | $17.53 | 2.56 |
| 2014-12-31 | 37.42 | $17.79 | 2.10 |
| 2014-09-30 | 34.92 | $17.94 | 1.95 |
| 2014-06-30 | 35.28 | $18.06 | 1.95 |
| 2014-03-31 | 32.59 | $18.00 | 1.81 |
| 2013-12-31 | 42.13 | $18.18 | 2.32 |
| 2013-09-30 | 39.88 | $18.27 | 2.18 |
| 2013-06-30 | 41.35 | $17.94 | 2.30 |
| 2013-03-31 | 41.66 | $17.06 | 2.44 |
| 2012-12-31 | 40.84 | $15.89 | 2.57 |
| 2012-09-30 | 40.10 | $14.95 | 2.68 |
| 2012-06-30 | 37.06 | $14.25 | 2.60 |
| 2012-03-31 | 34.84 | $14.10 | 2.47 |
| 2011-12-31 | 30.61 | $13.80 | 2.22 |
| 2011-09-30 | 29.24 | $13.51 | 2.16 |
| 2011-06-30 | 32.19 | $13.35 | 2.41 |
| 2011-03-31 | 32.77 | $13.26 | 2.47 |
| 2010-12-31 | 31.59 | $13.19 | 2.40 |
| 2010-09-30 | 29.27 | $12.91 | 2.27 |
| 2010-06-30 | 26.76 | $12.59 | 2.13 |
| 2010-03-31 | 28.58 | $12.36 | 2.31 |
| 2009-12-31 | 27.58 | $12.02 | 2.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.842B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |